NCT00002067已完成3 期
Phase III Randomized Double-Blind Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia
Bristol-Myers Squibb27 个研究点 分布在 1 个国家开始时间: 2001年8月31日最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 试验地点
- 27
研究概览
简要总结
To compare the effects of megestrol acetate and placebo on body weight, anorexia, cachexia, calorie intake, and nutritional parameters of patients with a confirmed diagnosis of AIDS. To determine whether megestrol acetate relative to placebo improves the perception of well-being among AIDS patients with cachexia. To evaluate megestrol acetate's effect on immune function via skin test reactivity, T4/T8 ratio, and total lymphocytes.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (27)
Loading locations...
相似试验
已完成
2 期
A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and MalnutritionAnorexiaCachexiaHIV InfectionsNCT00002300Bristol-Myers Squibb
终止
3 期
Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated SuspensionAnorexiaCachexiaWeight LossNCT00637806Par Pharmaceutical, Inc.4
终止
3 期
Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer PatientsAnorexiaCachexiaWeight LossNCT00637728Par Pharmaceutical, Inc.5
已完成
2 期
Study to Evaluate the Effect of Megestrol Acetate in Severe Chronic Obstructive Pulmonary Disease With Loss of WeightChronic Obstructive Pulmonary DiseaseNCT00507949Rottapharm Spain40
终止
2 期
Study to Evaluate the Effect of Megestrol Acetate in Weight Loss in Dementia PatientsDementiaNCT00503516Rottapharm Spain39